Toxicology Services - Drug and Alcohol Testing

Open

Buyers

Value

£0

Classifications

  • Blood analysers
  • Expert witness services
  • Laboratory services
  • Blood analysis services
  • Medical specialist services
  • Medical analysis services

Tags

  • planning

Submission Deadline

2 months from now

Published

5 days ago

Description

The GPhC wishes to inform the market of our intention to procure the provision of Toxicology Services - Drug and Alcohol Testing.
Where there are concerns regarding physical or mental health, specifically drug and alcohol misuse, the GPhC may necessitate a Pharmacy Registrant (donor) undergo medical assessment, forming part of a wider Fitness to Practise investigation.
In such cases, Toxicology Services (drug and alcohol testing) will be required to ascertain:
i.	if substance(s), as specified by the GPhC, have been used by the donor.
ii.	if substance(s), as specified by the GPhC, are being used by the donor.
Moreover, a Registrant may also be required to enter a period of 'medical supervision' - monitoring to confirm compliance with any restrictions on their registration. Here, Toxicology Services (drug and alcohol testing) will be required to verify fulfilment of conditions set.
The purpose of this notice is to raise awareness of our upcoming Request for Quotation sourcing activity, gauge accurate levels of market interest, and receive feedback on prospective plans/requirements in advance of the formal procurement process; to be announced in October 2025.
Scope of services will include, the:
1.	Supply of Phlebotomists and Specimen Collectors -throughout Great Britain- to collect donor samples: hair (head and body), nail, saliva, blood and urine.
2.	Undertaking of sample drug testing for, but not limited to amphetamines, benzodiazepines, cannabinoids, cocaine, hallucinogens, hypnotic substances, ketamine, mephedrone, methadone, methamphetamines (including MDMA and MDEA), novel psychoactive substances, opiates, opioids, sedatives, steroids and tramadol.
3.	Undertaking of sample alcohol -ethanol- testing; including phosphatidyl ethanol (PEth), carbohydrate-deficient transferrin (CDT) and fatty acid ethyl esters (FAEE) biomarkers, and ethyl glucuronide (EtG). 
4.	Undertaking of liver blood testing, formerly known as liver function tests (LFT).
5.	Undertaking of full blood count testing (FBC), including mean corpuscular volume testing (MCV).
6.	Secure email provision of sample analysis results within 3 working days; including the provision of supplementary reports which interpret results in an accessible (free from technical jargon, where possible), clear and concise manner. 
7.	Provision of a Certificate of Analysis (CoA).
8.	Provision of testimony in the capacity of an Independent Expert Witness (where donor samples are tested for legal purposes). N.B. the Service Provider remains responsible for ensuring staff are adequately trained to undertake this requirement, if requested.
Please note, samples are to be collected at a donors' home residence, or a neutral site as determined by the Service Provider.
We kindly ask that all interested suppliers complete and submit this response form to Anna Kitoki, at [email protected] by 17:00 on 02.09.2025. 
Any interest shown does not constitute a commitment to participate; and failure to show interest does not restrict suppliers from participating in this and/or any other procurement process run by the GPhC.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Provision of Echo-cardiogram and Sickle Cell Trait testing for University Officer Training Corps (UOTC) Candidates - Tender Notice

To meet the needs of the University Officer Training Corps (UOTC) entry medical assessments as part of annual recruiting programme. The UOTC entry medicals are funded outside of the Recruiting Partnership Programme (RPP) contract and UOTC entry medicals require a commercial contract to provide the provisions of Echocardiograms (Echo) for approximately 90 x UOTC candidates and Sickle Cell Trait (SCT) blood testing for 300 candidates annually. As part of UOTC recruiting programme, UOTC Entry Medical Cell (UEMC) delivers entry medicals to circa 1800 university students/candidates annually who are interested in joining the UOTC. Recruiting Year (RY) 2025/26 will see an increase of candidates to circa 2200. The provision of Echo and SCT testing is a crucial part of the entry medical assessment process to confirm the suitability of candidates to join the UOTC.

Katy Reed

Katy Reed

Published 1 week ago
Open

Trialling Benthic eDNA Sampling Methods for Monitoring Marine Biodiversity

JNCC is undertaking an offshore survey to collect data to assist in monitoring the effectiveness of proposed fisheries management measures covering 42 English Marine Protected Areas (MPAs) including North-West of Jones Bank (NWJB) Marine Conservation Zone (MCZ). This survey is being utilised as an opportunity to investigate the effectiveness of various benthic environmental DNA (eDNA) sampling techniques for monitoring marine biodiversity, and to assess the performance of each method relative to the others to inform future monitoring methodology. JNCC wishes to commission a contract to undertake an analysis of marine taxa eDNA present in sediment and water samples to be collected at the seafloor on the TC25035 survey of North-West of Jones Bank MCZ. JNCC plan to trial three benthic eDNA collection methods within the survey area. 3. Project Background The RV Tom Crean will depart from Cork for the TC25035 survey on 9 September 2025 and return on 25 September 2025. Seventeen days of sampling will be carried out as part of the survey, focusing on data collection to support the assessment of potential fisheries management measures. The survey will gather data on the effects of reduced fishing pressure on the recovery of subtidal mud habitats, as well as of sea-pen and burrowing megafauna communities. North-West of Jones Bank MCZ is situated approximately 165 km offshore from the South-West of England. The site covers 399.14 km2 of continental shelf, and it contributes one of the largest areas of subtidal mud to the MPA network of all designated MCZs. For more information regarding NWJB MCZ please see https://jncc.gov.uk/our-work/north-west-of-jones-bank-mpa/. DNA and eDNA are increasingly utilised, cost-effective tools for monitoring biodiversity. Traces of DNA (e.g. from scales, faeces, skin, blood) left in the environment (e.g. water and sediments), called environmental DNA, are left behind by all organisms. Using molecular methods, such as eDNA metabarcoding, we can detect an organism's presence in the environment without directly observing it. eDNA techniques can provide high-resolution pictures of biodiversity from micro to macro scales and inform on assemblage composition and biological processes at reduced costs and time. Niskin bottles, metaprobes and sediment samples have been increasingly used in recent years to collect DNA from inshore marine waters, complementing existing traditional survey methods. However, application of these methods in offshore waters has been more limited. 4. Project Objectives As part of the offshore survey to North-West of Jones Bank MCZ, the primary research and development objective will be to trial three eDNA sampling techniques to fill significant knowledge gaps on the use of eDNA in offshore environments. To achieve this objective, the following research questions to be answered are: 1. Which benthic eDNA sampling methods are recommended for sampling offshore marine organisms based on the following factors? a. Quantity of DNA collected b. Quality of DNA collected 2. How do the following parameters compare among the benthic eDNA sampling methods? a. Species detected b. Species of conservation interest detected c. Species richness To answer these questions, JNCC plan to collect four eDNA samples using each of the three methods below, at four stations within the survey area. This will result in up to 48 eDNA samples plus six controls. eDNA source eDNA collection method Storage Sampling methods Water Sterivex filter 99% ethanol (volume tbc) Niskin bottles attached to a CTD from a depth 3 metres above the seafloor Water including sediment particles Gauze 50ml 99% ethanol Metaprobes attached to a towed camera sledge for 30 mins Sediment Sediment sample Frozen Sediment samples collected from a Day grab JNCC wishes to commission a contract to undertake this analysis of marine taxa eDNA in water and sediment samples collected on the TC25035 survey of NWJB. JNCC plan to collect a total of 54 samples. However, please note that the resulting sample number will depend on successful sampling delivery, which could be affected by factors such as weather. JNCC would like to use primers to test samples for the presence of marine vertebrates, fishes, invertebrates, meiofauna and bacteria. The successful contractor will undertake the analysis as set out below (Section 5) adhering to common standards. 5. Project Objectives: Detailed Tasks The tenderers should provide a quote broken down into the following elements: • Transport of 54 samples (48 eDNA samples plus six controls) from Cork, Ireland to the laboratory • Sample preparation and DNA extraction of 54 samples (48 eDNA samples plus six controls) • The per-sample analysis of: o 16 x niskin bottle eDNA samples plus two controls o 16 x metaprobe eDNA samples plus two controls o 16 x sediment eDNA samples plus two controls Using universal primers to target a full range of marine biodiversity such as: o Bacteria and archaea (e.g. marker 16S rRNA) o Meiofauna invertebrates (e.g. marker 18SSSU) o Invertebrates (e.g. marker CO1LB) o Fish (e.g. marker 12STele) o Vertebrates (e.g. marker 16SMV3) • Delivery of a final report, to include: o Introduction and aims o Methods o Results o Discussion o Recommendations for future offshore monitoring The methods section of the report should share sufficient detail for the study to be repeated. It should cover: • Clear field protocol detailing eDNA sampling and storage for method comparison and validation. • DNA extraction methods - including the names of kits if used. State how the DNA was quantified and discuss the quality of DNA extracted. • PCR amplification - specify the primers, PCR cycle conditions and reagents used. • Sequencing - detail how the DNA products were prepared for sequencing including reagents, primers and conditions. State how the DNA was quantified, and the model of the sequencing machine used. In addition, the methods should allow the reader to understand the confidence in the sequences obtained. • Bio-informatic processing: State in detail how the bio-informatic processing was completed, by specifying the steps taken. State any programs that were used. • State any reference libraries used, and if a custom database was created the rules used. • Where sequences are being used for taxonomic assignment, please explain the methods used to assign a species and why any reads may have been discarded. The results and discussion sections of the report should include the following: • The efficiency of DNA extraction and correct amplification of expected PCR products at each stage. • A discussion of any problems and how they were resolved, such as issues with PCR leading to a change of reagents or amplification conditions. • A detailed discussion explaining the results and confidence levels of the bioinformatic processing. • Detailed results, including statistical analysis of data, to address Questions 1 and 2 above. • To answer Question 2b, the results should include tables on species of interest, detected using each method. The list (to be provided by JNCC) includes UK BAP Priority Species, OSPAR Threatened and/or Declining Species, Annex II species, Species listed as Features of Conservation Interest (FOCI), and invasive non-native species. Tenderers are invited to provide a description of how these requirements will be met. Please ensure you provide a quote per sample. Please also include details of internal quality assurance processes to ensure quality is assured in the project outputs. For example, this could include inclusion of negative control DNA extraction samples, quantification and purity checks to assess DNA yield and quality, and review of the project report by multiple experts. 6. Outputs Any products or outputs submitted to JNCC should adhere to JNCC's house-style and should be produced in an accessible format (see product specification for more information). Output / Deliverable Format Spreadsheet listing the species identified (Latin and common names) the fragment of DNA extracted as part of the study identified as that species, and the reference library and sequence ID used to identify the species MS Excel spreadsheet (.xlsx) (proforma to be provided by JNCC) All raw sequence data generated FASTQ format Final report MS Word document (.docx) and Adobe PDF (.pdf) 7. Product Specification JNCC is committed to making its publicly available resources and documents accessible, in accordance with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018. Making material accessible means making sure it can be used by as many people as possible. This includes those with:  impaired vision  motor difficulties  cognitive impairments or learning disabilities  deafness or impaired hearing The outputs and material that JNCC publishes should be compliant with the Web Content Accessibility Guidelines version 2.1 AA standard. To meet this standard, all reports and other documentation which are to be made publicly available must adhere to JNCC's house-style (to be provided) and be produced using a JNCC template (to be provided), unless otherwise stated. All reports (draft and final) should be provided electronically via email both as a Microsoft Word document and an Adobe PDF. Copies of documentation associated with case studies should be provided in electronic format with an associated reference catalogue. For any other outputs or products which are to be made publicly available through JNCC, evidence regarding how the accessibility standard will be reached should be included.

Katy Reed

Katy Reed

Published 1 week ago
Open

Protective Security Centre Substance Testing

This is a Tender Notice for potential bidders offering the opportunity to bid for The Home Office Protective Security Centre (PSC) Substance Testing Contract. The Buyer wishes to appoint a supplier to provide a Four (4) year Contract to provide Substance Testing as set out in the Statement of Requirements within the tender documents. The Buyer is using Jaggaer for this procurement which means the Tender is available only in electronic form. https://homeoffice.app.jaggaer.com/ The Invitation to Tender (ITT) can be viewed from the login page by anyone. However, you need to register and login to express interest and participate in the ITT. Bidders are required to complete the Qualification, Technical and Commercial Envelopes. To Prepare and Submit ITT Response Supplier responses can be configured within JAGGAER ONE, to do so: Navigate to Sourcing > ITT. Select from the sub-menu items: - ITTs Open to All Suppliers

Katy Reed

Katy Reed

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Katy Reed

Public authority - sub-central government

Timeline planned

Publish
Bid
Evaluate
Award
Complete